These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36789652)
1. Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma. Ament CE; Steinmann S; Evert K; Pes GM; Ribback S; Gigante I; Pizzuto E; Banales JM; Rodrigues PM; Olaizola P; Wang H; Giannelli G; Chen X; Evert M; Calvisi DF Hepatology; 2023 Dec; 78(6):1742-1754. PubMed ID: 36789652 [TBL] [Abstract][Full Text] [Related]
2. ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma. Chen F; Gao K; Li Y; Li Y; Wu Y; Dong L; Yang Z; Shi J; Guo K; Gao Q; Lu H; Zhang S Mol Cell Proteomics; 2024 Sep; 23(9):100821. PubMed ID: 39069074 [TBL] [Abstract][Full Text] [Related]
3. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways. Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357 [TBL] [Abstract][Full Text] [Related]
4. HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma. Cigliano A; Gigante I; Serra M; Vidili G; Simile MM; Steinmann S; Urigo F; Cossu E; Pes GM; Dore MP; Ribback S; Milia EP; Pizzuto E; Mancarella S; Che L; Pascale RM; Giannelli G; Evert M; Chen X; Calvisi DF J Exp Clin Cancer Res; 2024 Sep; 43(1):253. PubMed ID: 39243039 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic Roles of Laminin Subunit Gamma-2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation. Zhang J; Ji F; Tan Y; Zhao L; Zhao Y; Liu J; Shao L; Shi J; Ye M; He X; Jin J; Zhao B; Huang J; Roessler S; Zheng X; Ji J Adv Sci (Weinh); 2024 Jun; 11(21):e2309010. PubMed ID: 38526177 [TBL] [Abstract][Full Text] [Related]
6. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099 [TBL] [Abstract][Full Text] [Related]
7. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway. Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963 [TBL] [Abstract][Full Text] [Related]
8. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming. Colyn L; Alvarez-Sola G; Latasa MU; Uriarte I; Herranz JM; Arechederra M; Vlachogiannis G; Rae C; Pineda-Lucena A; Casadei-Gardini A; Pedica F; Aldrighetti L; López-López A; López-Gonzálvez A; Barbas C; Ciordia S; Van Liempd SM; Falcón-Pérez JM; Urman J; Sangro B; Vicent S; Iraburu MJ; Prosper F; Nelson LJ; Banales JM; Martinez-Chantar ML; Marin JJG; Braconi C; Trautwein C; Corrales FJ; Cubero FJ; Berasain C; Fernandez-Barrena MG; Avila MA J Exp Clin Cancer Res; 2022 May; 41(1):183. PubMed ID: 35619118 [TBL] [Abstract][Full Text] [Related]
9. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma. Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428 [TBL] [Abstract][Full Text] [Related]
10. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. Cigliano A; Zhang S; Ribback S; Steinmann S; Sini M; Ament CE; Utpatel K; Song X; Wang J; Pilo MG; Berger F; Wang H; Tao J; Li X; Pes GM; Mancarella S; Giannelli G; Dombrowski F; Evert M; Calvisi DF; Chen X; Evert K J Exp Clin Cancer Res; 2022 Jun; 41(1):192. PubMed ID: 35655220 [TBL] [Abstract][Full Text] [Related]
11. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells. Lu L; Hou X; Shi S; Körner C; Stanley P J Biol Chem; 2010 Nov; 285(46):36245-54. PubMed ID: 20837470 [TBL] [Abstract][Full Text] [Related]
12. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells. Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017 [TBL] [Abstract][Full Text] [Related]
13. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway. Indramanee S; Sawanyawisuth K; Silsirivanit A; Dana P; Phoomak C; Kariya R; Klinhom-On N; Sorin S; Wongkham C; Okada S; Wongkham S Sci Rep; 2019 Nov; 9(1):17266. PubMed ID: 31754244 [TBL] [Abstract][Full Text] [Related]
14. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses. Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304 [TBL] [Abstract][Full Text] [Related]
15. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition. Mancarella S; Gigante I; Serino G; Pizzuto E; Dituri F; Valentini MF; Wang J; Chen X; Armentano R; Calvisi DF; Giannelli G J Exp Clin Cancer Res; 2022 Nov; 41(1):331. PubMed ID: 36443822 [TBL] [Abstract][Full Text] [Related]
16. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. Mancarella S; Serino G; Gigante I; Cigliano A; Ribback S; Sanese P; Grossi V; Simone C; Armentano R; Evert M; Calvisi DF; Giannelli G J Exp Clin Cancer Res; 2022 Feb; 41(1):65. PubMed ID: 35172861 [TBL] [Abstract][Full Text] [Related]
17. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. Alvisi G; Termanini A; Soldani C; Portale F; Carriero R; Pilipow K; Costa G; Polidoro M; Franceschini B; Malenica I; Puccio S; Lise V; Galletti G; Zanon V; Colombo FS; De Simone G; Tufano M; Aghemo A; Di Tommaso L; Peano C; Cibella J; Iannacone M; Roychoudhuri R; Manzo T; Donadon M; Torzilli G; Kunderfranco P; Di Mitri D; Lugli E; Lleo A J Hepatol; 2022 Nov; 77(5):1359-1372. PubMed ID: 35738508 [TBL] [Abstract][Full Text] [Related]
18. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice. Lu X; Peng B; Chen G; Pes MG; Ribback S; Ament C; Xu H; Pal R; Rodrigues PM; Banales JM; Evert M; Calvisi DF; Chen X; Fan B; Wang J Am J Pathol; 2021 Sep; 191(9):1651-1667. PubMed ID: 34129844 [TBL] [Abstract][Full Text] [Related]